Anne Nagengast Johnson is Chief Financial Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 140,045 shares of ATAI, which is worth approximately $385,123. The most recent transaction as insider was on Mar 21, 2025, when has been sold 33,545 shares (Common Shares) at a price of $1.35 per share, resulting in proceeds of $45,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K
0% 3M change
90.3% 12M change
Total Value Held $385,123

Anne Nagengast Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2025
SELL
Open market or private sale
$45,285 $1.35 p/Share
33,545 Reduced 19.32%
140,045 Common Shares
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
100,000 Added 36.55%
173,590 Common Shares
Apr 02 2024
SELL
Open market or private sale
$50,708 $1.85 p/Share
27,410 Reduced 27.14%
73,590 Common Shares
Mar 14 2024
BUY
Exercise of conversion of derivative security
-
100,000 Added 49.75%
101,000 Common Shares
ANJ

Anne Nagengast Johnson

Chief Financial Officer
Berlin, 2M

Track Institutional and Insider Activities on ATAI

Follow ATAI Life Sciences N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATAI shares.

Notify only if

Insider Trading

Get notified when an Atai Life Sciences N.V. insider buys or sells ATAI shares.

Notify only if

News

Receive news related to ATAI Life Sciences N.V.

Track Activities on ATAI